Effect of fixed‐dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS‐ROZE (Multicenter Randomized Study of …

KJ Kim, SH Kim, YW Yoon, SW Rha… - Cardiovascular …, 2016 - Wiley Online Library
Aim We aimed to compare the effects of fixed‐dose combinations of ezetimibe plus
rosuvastatin to rosuvastatin alone in patients with primary hypercholesterolemia, including a …

Efficacy and safety of ezetimibe and rosuvastatin combination therapy versus those of rosuvastatin monotherapy in patients with primary hypercholesterolemia

W Kim, YE Yoon, SH Shin, JW Bae, BK Hong… - Clinical Therapeutics, 2018 - Elsevier
Purpose The aim of this study was to evaluate the safety and efficacy of combination
treatment of rosuvastatin with ezetimibe in patients with primary hypercholesterolemia …

[HTML][HTML] A phase III, multicenter, randomized, double-blind, active comparator clinical trial to compare the efficacy and safety of combination therapy with ezetimibe and …

SJ Hong, HS Jeong, JC Ahn, DH Cha, KH Won… - Clinical …, 2018 - Elsevier
Purpose Combination therapy with ezetimibe and statins is recommended in cases of statin
intolerance or insufficiency. The objective of this study was to compare the efficacy and …

Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study)

HE Bays, MH Davidson, R Massaad, D Flaim… - The American journal of …, 2011 - Elsevier
The present multicenter, 6-week, randomized, double-blind, parallel-group, clinical trial
evaluated the safety and efficacy of ezetimibe (10 mg) added to stable rosuvastatin therapy …

Rosuvastatin and ezetimibe for the treatment of dyslipidemia and hypercholesterolemia

C Boutari, A Karagiannis, VG Athyros - Expert review of …, 2021 - Taylor & Francis
Introduction: Statins are powerful lipid-lowering agents which reduce cardiovascular (CV)–
related morbidity and mortality. However, a large proportion of patients cannot attain the …

Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials

A Catapano, WE Brady, TR King… - … medical research and …, 2005 - Taylor & Francis
Objective: Results of direct comparative studies between ezetimibe/simvastatin and
rosuvastatin therapies have not been reported. Both of these treatment options offer …

Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular risk

V Barrios, C Escobar - Expert Review of Clinical Pharmacology, 2021 - Taylor & Francis
Introduction: Reducing low-density lipoprotein cholesterol (LDL-C) with lipid-lowering
therapies has been associated with a decrease in the frequency of cardiovascular events …

Combination therapy of rosuvastatin and ezetimibe in patients with high cardiovascular risk

YJ Yang, SH Lee, BS Kim, YK Cho, HJ Cho… - Clinical …, 2017 - Elsevier
Purpose The aim of this study was to evaluate the efficacy and tolerability of
rosuvastatin/ezetimibe combination therapy in Korean patients with high cardiovascular risk …

Rosuvastatin/ezetimibe: a review in hypercholesterolemia

YN Lamb - American journal of cardiovascular drugs, 2020 - Springer
Rosuvastatin/ezetimibe combines two lipid-lowering agents: rosuvastatin, an HMG-CoA
reductase inhibitor (ie statin) with particularly strong inhibitory effects on hepatic cholesterol …

Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients

AL Catapano, MH Davidson… - … medical research and …, 2006 - Taylor & Francis
Objective: To assess the lipid-altering efficacy and safety of ezetimibe/simvastatin single
tablet product compared with rosuvastatin at the approved usual starting, next highest, and …